Gilead Sciences
GILD
$66.34
Share price
-0.87%
Change (1 day)
-20.67%
Change (1 year)
Categories
Number of shares outstanding for Gilead Sciences (GILD)
Number of shares outstanding as of April 2024 : 1,248,000,000
According to Gilead Sciences's latest financial reports and stock price the company's current number of shares outstanding is 1,248,000,000. At the end of 2023 the company had 1,248,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Gilead Sciences from 2013 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 1.24 B | -0.32% |
| 2022 | 1.25 B | -0.32% |
| 2021 | 1.25 B | 0.08% |
| 2020 | 1.25 B | -0.87% |
| 2019 | 1.26 B | -1.86% |
| 2018 | 1.29 B | -1.3% |
| 2017 | 1.30 B | -0.68% |
| 2016 | 1.31 B | -8.36% |
| 2015 | 1.43 B | -4.65% |
| 2014 | 1.50 B | -1.82% |
| 2013 | 1.53 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 92.88% | 🇺🇸 USA |
 Pfizer PFE | 5,647,000,000 | 352.48% | 🇺🇸 USA |
 AbbVie ABBV | 1,765,940,733 | 41.50% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | -23.93% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | -57.13% | 🇺🇸 USA |
 Biogen BIIB | 144,800,000 | -88.40% | 🇺🇸 USA |
 Illumina ILMN | 158,000,000 | -87.34% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | 258,000,000 | -79.33% | 🇺🇸 USA |
 Merck MRK | 2,554,166,667 | 104.66% | 🇺🇸 USA |